Grifols Partnership is a specialized CDMO dedicated to developing and producing high-quality sterile injectable solutions, with a strong focus on small-molecule parenteral products. Drawing on more than 85 years of Grifols' global pharmaceutical expertise, the CDMO division combines technical know-how, advanced industrial capabilities and a strong quality culture to deliver reliable, end-to-end manufacturing solutions worldwide.

Chưa có bình luận nào.
Để lại đánh giá & nhận xét